Stay updated on Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.

Latest updates to the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe INO-4800 Phase 1 study record is now displayed, including its design, eligibility criteria, interventions, outcomes, and participant-data sharing details, instead of a 403 error page.SummaryDifference47%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating restricted access to the record, with the standard header and footer visible but no study details accessible.SummaryDifference18%

Stay in the know with updates to Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.